- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MARPAI Aktie jetzt für 0€ handeln | |||||
| 01.12.25 | Marpai meldet starke Vertriebserfolge für 2026 und verlängert Vereinbarung mit Aetna | 12 | Investing.com Deutsch | ||
| 01.12.25 | Marpai reports strong 2026 sales and renews Aetna network agreement | 6 | Investing.com | ||
| 13.11.25 | Marpai verfehlt Gewinnerwartungen - Aktie bricht um 20 % ein | 2 | Investing.com Deutsch | ||
| 13.11.25 | Marpai GAAP EPS of -$0.20, revenue of $4.03M | 1 | Seeking Alpha | ||
| 12.11.25 | Marpai Reports Third Quarter 2025 Financial Results | 95 | PR Newswire | Continued Turnaround Driven by Cost Discipline and Operational Efficiency; Positioned for Strong 2026 Growth
TAMPA, Fla., Nov. 12, 2025 /PRNewswire/ -- Marpai... ► Artikel lesen | |
| 12.11.25 | Marpai, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.11.25 | Marpai, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 06.10.25 | Marpai receives $200,000 investment from CEO's investment fund | 1 | Investing.com | ||
| 06.10.25 | Marpai raises $200K in private placement with CEO-backed HillCour Investment | 1 | Seeking Alpha | ||
| 06.10.25 | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.09.25 | Marpai, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 29.08.25 | Führungswechsel bei Marpai: Dallas Scrip wird neuer Präsident nach Rücktritt von John Powers | 1 | Investing.com Deutsch | ||
| 27.08.25 | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.08.25 | Marpai GAAP EPS of -$0.28, revenue of $4.6M | 1 | Seeking Alpha | ||
| 13.08.25 | Marpai, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.08.25 | Marpai Reports Second Quarter 2025 Financial Results | 371 | PR Newswire | Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability.Operating Expenses Cut 70% as Turnaround Gains Traction
TAMPA, Fla., Aug. 13,... ► Artikel lesen | |
| 04.08.25 | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05.25 | Marpai Reports First Quarter 2025 Financial Results | 145 | PR Newswire | Marpai's turnaround momentum is building
TAMPA, Fla., May 14, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative... ► Artikel lesen | |
| 13.05.25 | Marpai Hires Dallas Scrip As Chief Operating Officer | 152 | PR Newswire |
Marpai Bolsters Leadership Team to Drive Profitable High-Growth Strategy with Key Executive Appointment
TAMPA, Fla., May 13, 2025 /PRNewswire/ -- Marpai, Inc.... ► Artikel lesen | |
| 26.03.25 | Marpai Reports Fourth Quarter And Full Year 2024 Financial Results | 166 | PR Newswire | MARPAI EXHIBITS STRONG, ONGOING FINANCIAL IMPROVEMENT
TAMPA, Fla., March 26, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,370 | -0,56 % | DAX-Check LIVE: Commerzbank, Fresenius, Jost Werke, Nordex, Symrise, TKMS, Volkswagen Vz., Zalando | Der DAX ist mit weiteren Rekorden in die neue Woche gestartet und hat erstmals die Marke von 25.400 Punkten überschritten. Im Tageshoch erreichte der Leitindex 25.421 Punkte und markierte damit den... ► Artikel lesen | |
| TELADOC HEALTH | 5,609 | +3,68 % | Teladoc Health Unveils New Capabilities to Treat More Conditions and Detect Care Gaps Earlier | ||
| NUGEN MEDICAL DEVICES | 0,018 | -5,26 % | NuGen Medical Devices Inc.: NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress | Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is providing... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,547 | +2,63 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy | Designation further supports (Z)-Endoxifen program into rare pediatric neuromuscular disease along with previously received Rare Pediatric Disease Designation
SEATTLE... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,172 | 0,00 % | Co-Diagnostics droht Delisting von der NASDAQ - Handel soll im OTC-Markt fortgesetzt werden | ||
| MEMPHASYS | 0,003 | 0,00 % | MEMPHASYS LIMITED: Application for quotation of securities - MEM | ||
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| ASSURANCE HEALTHCARE | 0,006 | 0,00 % | ASSURANCE HEALTHCARE LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::HALF YEARLY RESULTS | ||
| INVO FERTILITY | 0,812 | +0,11 % | INVO Fertility, Inc.: INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026 | ||
| VENUS CONCEPT | 7,940 | +455,24 % | Venus Concept Stock Explodes Over 500% After Major Investor Takes Control | ||
| ALIGNMENT HEALTHCARE | 22,500 | 0,00 % | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 | Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,650 | -4,59 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers auf "Outperform" mit einem Kursziel von 52,90 Euro belassen. 2025 sei ein schlechtes Jahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,100 | +0,46 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung gemäß Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014 und Artikel 2 Abs. 1 der Delegierten... ► Artikel lesen | |
| GENEDX | 108,08 | -1,10 % | Sema4.ai: Interview With Co-Founder & CEO Rob Bearden About The Enterprise AI Agent Platform | ||
| BRIGHTSPRING HEALTH SERVICES | 39,200 | -1,01 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen |
Das Unternehmen MARPAI INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MARPAI INC finden Sie auf Wallstreet Online.